Nutex Health (NASDAQ:NUTX) Sees Large Volume Increase Following Analyst Upgrade

Shares of Nutex Health Inc. (NASDAQ:NUTX) saw an uptick in trading volume on Friday after Benchmark raised their price target on the stock from $150.00 to $300.00. Benchmark currently has a buy rating on the stock. 46,510 shares traded hands during trading, a decline of 29% from the previous session’s volume of 65,303 shares.The stock last traded at $161.20 and had previously closed at $173.76.

Separately, Maxim Group raised their price target on Nutex Health from $75.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 8th.

Insider Transactions at Nutex Health

In other news, CFO Jon Christian Bates bought 1,000 shares of Nutex Health stock in a transaction dated Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the completion of the acquisition, the chief financial officer now owns 4,888 shares of the company’s stock, valued at $399,887.28. This trade represents a 25.72% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 38.52% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

Large investors have recently made changes to their positions in the company. Bank of America Corp DE increased its holdings in shares of Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after purchasing an additional 2,043 shares during the last quarter. Northern Trust Corp purchased a new position in Nutex Health in the fourth quarter worth about $200,000. Baader Bank Aktiengesellschaft purchased a new position in Nutex Health in the fourth quarter worth about $206,000. Millennium Management LLC purchased a new position in Nutex Health in the fourth quarter worth about $213,000. Finally, World Investment Advisors purchased a new position in Nutex Health in the fourth quarter worth about $217,000. 5.32% of the stock is owned by institutional investors.

Nutex Health Trading Up 0.5%

The company has a market cap of $965.80 million, a PE ratio of -18.61 and a beta of -0.10. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The company has a 50-day moving average of $101.77 and a 200 day moving average of $61.17.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, topping the consensus estimate of ($0.15) by $2.71. The company had revenue of $211.79 million during the quarter, compared to analyst estimates of $81.09 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.